Literature DB >> 1173981

Age related changes in free plasma testosterone, dihydrotestosterone and oestradiol.

K M Pirke, P Doerr.   

Abstract

The age related changes on free plasma testosterone (T), dihydrotestosterone (DHT) and oestradiol (OE2) were determined in 82 healthy adult males. Forty-six subjects were between 22 and 61 years of age (group I), 36 between 67 and 93 years (group II). The percentage of free, non protein bound hormone was determined by equilibrium dialysis of undiluted plasma against isotonic phosphate buffer at 37 degrees C. Total hormone concentrations were measured by radioimmunoassay. The percentage of free T was 2.24% (median), 1.65-3.42 (95 percentiles) in group I and 1.65% (1.24-2.26) in group II. The percentage of free DHT decreased from 1.17% (0.80-2.03) in group I to 0.83% (0.52-1.55) in group II. The decrease in % free Oe2 was only very small: group I = 2.49% (2.13-2.96), ad group II = 2.31% (1.95-3.17). The fall in free T by 43.3% from 12.2 ng/100 ml (6.74-25.0) in group I to 6.90 ng/ml (3.57-10.6) in group II was twice as high as that of total T, which decreased on an average by 20.6%. Free DHT decreased by 25.8%: group I = 578 pg/100 ml (266-987), group II =429 pg/100 ml (168-723), while total DHT was not significantly different between the two groups (-1.9%). Free Oe2 was increased in old age: group I = 42.4 PG/100 ML (26.0-69.4), GROUP II = 55.7 PG/100 ML (35.8-118.9). The increase in free Oe2 by 31.4% was almost as high as that of the total Oe2 (46.9%).

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1173981     DOI: 10.1530/acta.0.0800171

Source DB:  PubMed          Journal:  Acta Endocrinol (Copenh)        ISSN: 0001-5598


  12 in total

Review 1.  Androgens, aging, and Alzheimer's disease.

Authors:  Christian J Pike; Emily R Rosario; Thuy-Vi V Nguyen
Journal:  Endocrine       Date:  2006-04       Impact factor: 3.633

2.  Correlation between serum total testosterone and the AMS and IIEF questionnaires in patients with erectile dysfunction with testosterone deficiency syndrome.

Authors:  Jae Kang; Byeong Kuk Ham; Mi Mi Oh; Je Jong Kim; Du Geon Moon
Journal:  Korean J Urol       Date:  2011-06-17

3.  Testosterone and cardiovascular disease in men.

Authors:  Paul D Morris; Kevin S Channer
Journal:  Asian J Androl       Date:  2012-04-23       Impact factor: 3.285

4.  Pituitary gonadal system function in patients with erectile impotence and premature ejaculation.

Authors:  K M Pirke; G Kockott; J Aldenhoff; U Besinger; W Feil
Journal:  Arch Sex Behav       Date:  1979-01

5.  Age and sex related variations in biologically active and immunoreactive serum luteinizing hormone.

Authors:  P Marrama; A A Zaidi; V Montanini; M F Celani; K Cioni; C Carani; F Morabito; M Resentini; B Bonati; G F Baraghini
Journal:  J Endocrinol Invest       Date:  1983-12       Impact factor: 4.256

Review 6.  Androgen deficiency and aging in men.

Authors:  R S Swerdloff; C Wang
Journal:  West J Med       Date:  1993-11

7.  Spontaneous benign prostatic hyperplasia in the beagle. Age-associated changes in serum hormone levels, and the morphology and secretory function of the canine prostate.

Authors:  C B Brendler; S J Berry; L L Ewing; A R McCullough; R C Cochran; J D Strandberg; B R Zirkin; D S Coffey; L G Wheaton; M L Hiler; M J Bordy; G D Niswender; W W Scott; P C Walsh
Journal:  J Clin Invest       Date:  1983-05       Impact factor: 14.808

8.  17-hydroxyprogesterone, androstenedione, and testosterone in normal children and in prepubertal patients with congenital adrenal hyperplasia.

Authors:  K von Schnakenburg; F Bidlingmaier; D Knorr
Journal:  Eur J Pediatr       Date:  1980-05       Impact factor: 3.183

9.  Effects of acute stimulation with gonadotropin releasing hormone (GnRH) on biologically active serum luteinizing hormone (LH) in elderly men.

Authors:  M F Celani; V Montanini; G F Baraghini; C Carani; P Marrama
Journal:  J Endocrinol Invest       Date:  1984-12       Impact factor: 4.256

10.  Serum concentrations of sex hormones in men with severe lower urinary tract symptoms and benign prostatic hyperplasia.

Authors:  M Ozgür Tan; Ilhan Karabiyik; M Cemil Uygur; Yusuf Diker; Demokan Erol
Journal:  Int Urol Nephrol       Date:  2003       Impact factor: 2.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.